1 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow Mecapegfilgrastim: new trials by email Literature Review of Mecapegfilgrastim trials Research Report on Mecapegfilgrastim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC Mecapegfilgrastim, Adebrelimab, Docetaxel - GC/GEJC | Phase 2 | Not yet recruiting | The First Affiliated Hospital with Nanjing Medical University | 70 | 2024-11-30 | 2024-11-12 |
| Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer Mecapegfilgrastim, dalpiciclib, exemestane, fulvestrant, letrozole, tamoxifen - Metastatic Breast Cancer | Phase 2 | Active not recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 132 | 2022-08-01 | 2025-05-14 |
| Reverse Triple Negative Immune Resistant Breast Cancer Choline, anti-PD-1 antibody and chemotherapy, Sodium Cromoglicate - Triple-negative Breast Cancer | Phase 2 | Recruiting | Fudan University | 80 | 2022-06-30 | 2025-12-03 |
| Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis Mecapegfilgrastim - Small Cell Lung Cancer | Not applicable | Unknown | Tianjin Medical University Cancer Institute and Hospital | 93 | 2019-11-10 | 2019-11-21 |
Breast Neoplasms (1) · Small Cell Lung Carcinoma (1) · Triple Negative Breast Neoplasms (1)
Fudan University (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (4)